|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.518
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.223
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.221
|
Mouse |
|
dendrite development
|
GO:0016358 |
115 |
0.202
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.201
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.201
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.184
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.171
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.171
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.139
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.138
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.120
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.119
|
Mouse |
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.112
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.112
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.111
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.108
|
|
|
gland development
|
GO:0048732 |
330 |
0.105
|
|
|
anion transport
|
GO:0006820 |
177 |
0.103
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.102
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.102
|
|
|
histone modification
|
GO:0016570 |
159 |
0.102
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.101
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.099
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.099
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.098
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.094
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.092
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.091
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.090
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.089
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.089
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.089
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.088
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.088
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.087
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.087
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.086
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.085
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.084
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.083
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.083
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.083
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.082
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.081
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.079
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.078
|
|
|
branchiomotor neuron axon guidance
|
GO:0021785 |
7 |
0.077
|
|
|
tube formation
|
GO:0035148 |
140 |
0.077
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.075
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.074
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.073
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.072
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.072
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.071
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.070
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.070
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.068
|
|
|
ossification
|
GO:0001503 |
216 |
0.068
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.067
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.066
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.065
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.065
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.064
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.064
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.064
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.063
|
|
|
nerve development
|
GO:0021675 |
67 |
0.063
|
|
|
regulation of urine volume
|
GO:0035809 |
6 |
0.063
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.062
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.061
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.061
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.060
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.060
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.059
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.059
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.058
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.057
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.057
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.056
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.055
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.055
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.054
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.054
|
|
|
placenta development
|
GO:0001890 |
140 |
0.054
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.054
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.054
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.053
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.053
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.052
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.051
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.051
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.051
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.051
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.050
|
|
|
wound healing
|
GO:0042060 |
157 |
0.050
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.050
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.050
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.050
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.050
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.050
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.049
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.048
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.048
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.048
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.047
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.047
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.047
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.047
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.046
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.046
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.046
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.045
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.045
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.045
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.045
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.044
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.043
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.043
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.043
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.043
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.043
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.043
|
|
|
facial nerve structural organization
|
GO:0021612 |
10 |
0.042
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.042
|
|
|
appendage development
|
GO:0048736 |
166 |
0.042
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.042
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.041
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.041
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.041
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.041
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.041
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.041
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.041
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.040
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.040
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.040
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.040
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.039
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.039
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.038
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.038
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.038
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.038
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.038
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.038
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.038
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.038
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.038
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.038
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.038
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.038
|
|
|
positive regulation of urine volume
|
GO:0035810 |
6 |
0.037
|
|
|
defecation
|
GO:0030421 |
1 |
0.037
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.037
|
|
|
facial nerve development
|
GO:0021561 |
11 |
0.037
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.036
|
|
|
cranial nerve structural organization
|
GO:0021604 |
13 |
0.036
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.036
|
|
|
skin development
|
GO:0043588 |
220 |
0.036
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.036
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.036
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.036
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.036
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.036
|
|
|
regulation of aldosterone metabolic process
|
GO:0032344 |
1 |
0.035
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.035
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.035
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.035
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.035
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.035
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.035
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.035
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.035
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.034
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.034
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.034
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.034
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.034
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.034
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.034
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.034
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.034
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.034
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.034
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.033
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.033
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.033
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.033
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.032
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.032
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.032
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.032
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.032
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.032
|
|
|
facioacoustic ganglion development
|
GO:1903375 |
3 |
0.032
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.032
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.032
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.031
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.031
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.031
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.031
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.031
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.031
|
|
|
facial nerve morphogenesis
|
GO:0021610 |
11 |
0.031
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.030
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.030
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.030
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.030
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.030
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.030
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.030
|
|
|
renal system process
|
GO:0003014 |
48 |
0.030
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.030
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.030
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.030
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.029
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.029
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.029
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.029
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.029
|
|
|
pallium development
|
GO:0021543 |
120 |
0.029
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.028
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.028
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.028
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.028
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.028
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.028
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.028
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.028
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.028
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.028
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.028
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.028
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.028
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.027
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.027
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.027
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.027
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.027
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.027
|
|
|
action potential
|
GO:0001508 |
78 |
0.027
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.027
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.027
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.027
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.027
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.027
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.027
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.027
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
17 |
0.027
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.026
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.026
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.026
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.026
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.026
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.026
|
|
|
ventral trunk neural crest cell migration
|
GO:0036486 |
4 |
0.026
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.026
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.026
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.026
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.026
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.026
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.026
|
|
|
translation
|
GO:0006412 |
93 |
0.026
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.026
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.026
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.025
|
|
|
lung development
|
GO:0030324 |
164 |
0.025
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.025
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.025
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.025
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.025
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.025
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.025
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.025
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.025
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.025
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.025
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.025
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.025
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.024
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.024
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.024
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.024
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.024
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.024
|
|
|
sympathetic nervous system development
|
GO:0048485 |
22 |
0.024
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.024
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.024
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.024
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.024
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.024
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.024
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.023
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.023
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.023
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.023
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.023
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.023
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.023
|
|
|
positive regulation of myelination
|
GO:0031643 |
5 |
0.023
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.023
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.023
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.023
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.023
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.023
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.022
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.022
|
|
|
ear development
|
GO:0043583 |
200 |
0.022
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.022
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.022
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.022
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.022
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.022
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.022
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.022
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.022
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.022
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.022
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.022
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.022
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.022
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.022
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.022
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.021
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.021
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.021
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.021
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.021
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.021
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
tube closure
|
GO:0060606 |
91 |
0.021
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.021
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.021
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.021
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.021
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.021
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.021
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.021
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.021
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.021
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.021
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.020
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.020
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.020
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.020
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.020
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
cation transport
|
GO:0006812 |
399 |
0.020
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.020
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.020
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.020
|
|
|
determination of left right asymmetry in nervous system
|
GO:0035545 |
1 |
0.020
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.020
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.020
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.019
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.019
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.019
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.019
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.019
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.019
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.019
|
|
|
protein processing
|
GO:0016485 |
163 |
0.019
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.019
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.019
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.019
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.019
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.019
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.019
|
|
|
regionalization
|
GO:0003002 |
337 |
0.019
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.019
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.019
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.019
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.019
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.019
|
|
|
methylation
|
GO:0032259 |
134 |
0.019
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.019
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.019
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.018
|
|
|
fasciculation of sensory neuron axon
|
GO:0097155 |
3 |
0.018
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.018
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.018
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.018
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.018
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.018
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.018
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.018
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.018
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.018
|
|
|
hypothalamic tangential migration using cell axon interactions
|
GO:0021856 |
3 |
0.018
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.018
|
|
|
coagulation
|
GO:0050817 |
78 |
0.018
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.018
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.018
|
|
|
calcium mediated signaling using intracellular calcium source
|
GO:0035584 |
3 |
0.018
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.018
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.018
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.018
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.018
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.018
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.017
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.017
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.017
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.017
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.017
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.017
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.017
|
|
|
regulation of chorionic trophoblast cell proliferation
|
GO:1901382 |
1 |
0.017
|
|
|
homophilic cell adhesion via plasma membrane adhesion molecules
|
GO:0007156 |
18 |
0.017
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.017
|
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
20 |
0.017
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.017
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.017
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.017
|
|
|
renal system development
|
GO:0072001 |
225 |
0.017
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.017
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.017
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.017
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.016
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.016
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.016
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.016
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.016
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.016
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.016
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.016
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.016
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.016
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.016
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.016
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.016
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.016
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.016
|
|
|
positive regulation of retinal ganglion cell axon guidance
|
GO:1902336 |
2 |
0.016
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.016
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.016
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.016
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.016
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.016
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.016
|
|
|
embryonic nail plate morphogenesis
|
GO:0035880 |
3 |
0.015
|
|
|
fc receptor mediated stimulatory signaling pathway
|
GO:0002431 |
4 |
0.015
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.015
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.015
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.015
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.015
|
|
|
bone development
|
GO:0060348 |
120 |
0.015
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.015
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.015
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.015
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.015
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.015
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.015
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.015
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.015
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.015
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.015
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.015
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.015
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.015
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.015
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.015
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.015
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.015
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.014
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.014
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.014
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.014
|
|
|
regulation of heart rate by chemical signal
|
GO:0003062 |
4 |
0.014
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
cell growth
|
GO:0016049 |
130 |
0.014
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.014
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.014
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.014
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.014
|
|
|
palate development
|
GO:0060021 |
76 |
0.014
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.014
|
|
|
olfactory nerve development
|
GO:0021553 |
3 |
0.014
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.014
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.014
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.014
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.014
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.014
|
|